Analysts Are Bullish on Top Technology Stocks: Cellebrite DI (CLBT), PDF Solutions (PDFS)

There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Cellebrite DI (CLBT – Research Report) and PDF Solutions (PDFS – Research Report) with bullish sentiments.

Elevate Your Investing Strategy:

• Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Cellebrite DI (CLBT)

In a report released today, Jeff Van Rhee from Craig-Hallum maintained a Buy rating on Cellebrite DI. The company’s shares closed last Thursday at $19.35.

According to TipRanks.com, Rhee is a 5-star analyst with an average return of 19.4% and a 55.4% success rate. Rhee covers the Technology sector, focusing on stocks such as Intellicheck Mobilisia, Frequency Electronics, and Alkami Technology. ;'>

Currently, the analyst consensus on Cellebrite DI is a Strong Buy with an average price target of $21.29, implying a 10.3% upside from current levels. In a report issued on October 13, William Blair also maintained a Buy rating on the stock.

See Insiders’ Hot Stocks on TipRanks >>

PDF Solutions (PDFS)

In a report released today, Christian Schwab from Craig-Hallum maintained a Buy rating on PDF Solutions. The company’s shares closed last Thursday at $28.33.

According to TipRanks.com, Schwab is a 5-star analyst with an average return of 14.0% and a 60.5% success rate. Schwab covers the Technology sector, focusing on stocks such as Ribbon Communications, Ultra Clean Holdings, and Axcelis Technologies. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for PDF Solutions with a $26.50 average price target, representing a -4.3% downside. In a report issued on October 2, Rosenblatt Securities also maintained a Buy rating on the stock with a $31.00 price target.

Read More on CLBT:

Disclaimer & DisclosureReport an Issue

• Cellebrite expands reach with Agentic AI, announces its Autumn 2025 release
• Cellebrite DI: Positioned for Growth with Strategic Market Expansion and AI Integration
• Cellebrite price target raised to $23 from $20 at JPMorgan
• Cellebrite DI Shareholders Approve Proposals at Annual Meeting
• Cellebrite DI’s Strategic Growth and Market Expansion: Analyst Recommends Buy Rating